SCHEMBL4480741

SCHEMBL4480741

CCS(=O)(=O)N(CCN(C)C)c1ccc(NC(=C2C(=O)Nc3cc(F)ccc32)c2ccccc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.38
FLT3 P36888 2/20 0.36
BRD4 O60885 4/20 0.36
PDGFRB P09619 2/20 0.35
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
MAPT P10636 3/20 0.33
HTT P42858 2/20 0.33
ALDH1A1 P00352 2/20 0.33
LMNA P02545 2/20 0.33
TP53 P04637 2/20 0.33
HPGD P15428 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
POLB P06746 2/20 0.33
CETP P11597 1/20 0.33
KDM4E B2RXH2 1/20 0.32
AURKA O14965 1/20 0.32
PDGFRA P16234 1/20 0.32
KDR P35968 1/20 0.32
AURKB Q96GD4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4480738 1.00 BACE1 (0.38) BACE1FLT3BRD4PDGFRBMEN1
SCHEMBL4492980 0.96 BACE1 (0.36) BACE1FLT3BRD4PDGFRBMEN1
SCHEMBL4492981 0.96 BACE1 (0.36) BACE1FLT3BRD4PDGFRBMEN1
SCHEMBL4503037 0.94 FLT3 (0.35) BACE1FLT3BRD4PDGFRBMEN1
SCHEMBL4503042 0.94 FLT3 (0.35) BACE1FLT3BRD4PDGFRBMEN1
SCHEMBL4485545 0.93 RORC (0.37) BACE1FLT3BRD4PDGFRBMEN1
SCHEMBL4485541 0.93 RORC (0.37) BACE1FLT3BRD4PDGFRBMEN1
SCHEMBL4484967 0.92 BACE1 (0.38) BACE1FLT3BRD4PDGFRBMEN1
SCHEMBL4484962 0.92 BACE1 (0.38) BACE1FLT3BRD4PDGFRBMEN1
SCHEMBL4486037 0.90 BACE1 (0.36) BACE1FLT3BRD4PDGFRBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR BACE1 1615/4885FLT3 34/4885BRD4 2704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.